(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid sodium salt
ATORVASTATIN SODIUM
CAS: 134523-01-6
Molecular Formula: C33H36FN2NaO5
(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid sodium salt - Names and Identifiers
| Name | ATORVASTATIN SODIUM |
| Synonyms | ATORVASTATIN SODIUM Atorvastatin D5 sodium Atorvastatin Sodium 134523-01-6 (3R,5R)-Atorvastatin Sodium Salt Atorvastatin Sodium 134523-01-6 (3R,5R)-7-[3-(Phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt (3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid sodium salt sodium (3R,5S)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-4,5-dihydropyrrol-1-yl]-3,5-dihydroxy-heptanoate [R-(R',R')]-2-(4-Fluorophenyl)-3-phenyl-4-[(phenylamino)carbonyl]-5-(1-methylethyl)-1-H-pyrrol-1-(-dihydrogen)heptanoic acid sodium |
| CAS | 134523-01-6 |
| EINECS | 1806241-263-5 |
| InChI | InChI=1/2C33H35FN2O5.Ca.Na/c2*1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;;/h2*3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);;/q;;+2;/p-2/t2*26-,27-;;/m10../s1 |
(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid sodium salt - Physico-chemical Properties
| Molecular Formula | C33H36FN2NaO5 |
| Molar Mass | 582.65 |
| Melting Point | >200°C (dec.) |
| Solubility | Methanol (Slightly), Water (Slightly) |
| Appearance | Solid |
| Color | Pale Yellow |
| pKa | 4.46(at 25℃) |
| Storage Condition | Hygroscopic, -20°C Freezer, Under inert atmosphere |
(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid sodium salt - Reference
| Reference Show more | 1. [IF=2.649] Zhenhua He et al."Atorvastatin Enhances Effects of Radiotherapy on Prostate Cancer Cells and Xenograft Tumor Mice Through Triggering Interaction Between Bcl-2 and MSH2."Med Sci Monitor. 2020; 26: e923560-1–e923560-12 |
![(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid sodium salt](http://res.chembk.com/assets/images/structure/134523-01-6.gif)
Supplier List
Product Name: ATORVASTATIN SODIUM Visit Supplier Webpage Request for quotation
CAS: 134523-01-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 134523-01-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Product Name: ATORVASTATIN SODIUM Visit Supplier Webpage Request for quotation
CAS: 134523-01-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 134523-01-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History
(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid sodium salt
880345-50-6
880345-50-6